Medical Liability & Tort Reform Statistics (2026): Caps, Premiums, and Evidence

Medical liability tort reform is one of the most studied and most contested areas of health policy. Damage caps, the signature reform, are meant to lower premiums, stabilize physician supply, and curb defensive medicine. The evidence supports some of those claims strongly and others weakly, and courts remain divided on whether caps are even constitutional. This is an evenhanded look at what the data actually shows.

What's in This Guide

1The State-by-State Landscape

The single most important fact about medical liability is that there is no national system. Each state sets its own rules, and the result is a patchwork in which the same injury can yield very different recoveries depending on where it occurred.

As of 2026, roughly half of U.S. states maintain some form of medical malpractice damages cap, though the exact count depends on how one treats caps that have been struck down, total-damage versus non-economic caps, and states with constitutional prohibitions. Published tallies range from about 24 to 29 cap states. Most caps target only non-economic damages, the pain, suffering, and loss-of-consortium losses that cannot be documented with receipts, while economic damages such as medical bills and lost income remain uncapped in every state. A smaller group of states, including Colorado, Indiana, Louisiana, Nebraska, New Mexico, and Virginia, apply a total cap covering both categories.

The mechanics vary widely even among cap states. Some apply the ceiling per claim, others per occurrence regardless of the number of plaintiffs; some build in inflation adjustments or scheduled increases; and some set different caps for different provider types. Virginia, for example, uses a single sliding-scale total cap that increases each year, reaching about $2.55 million for acts occurring in 2023. This structural diversity means that generalizations about tort reform obscure enormous state-level variation, which is exactly why the empirical studies reach different conclusions depending on which states and years they examine.

Source: State-by-state damage caps overview (legal reference) | Caps on compensatory damages, state law summary

2MICRA, the Model Reform

Every discussion of tort reform begins with one statute, because it created the template that dozens of states copied. Its recent modernization also illustrates how these caps evolve under political and legal pressure.

California's Medical Injury Compensation Reform Act, enacted in 1975 during the first malpractice insurance crisis, capped non-economic damages at $250,000 and became the blueprint for later reforms nationwide. That figure remained frozen for nearly half a century, which critics argued had eroded its real value dramatically through inflation. In 2022, following a ballot-measure campaign, California enacted Assembly Bill 35, which began raising the cap in January 2023. Under the scheduled increases, the cap reached roughly $470,000 for personal injury and $650,000 for wrongful death by January 2026, and it continues to rise annually toward $750,000 and $1 million respectively by 2033, with inflation adjustments thereafter.

MICRA's arc captures the entire tort-reform debate in miniature. It was enacted to address a premium crisis, it became the most-copied reform in the country, and after decades it was substantially loosened through a negotiated compromise between physician groups and patient advocates. The fact that even MICRA, the reform proponents most often cite as a success, was ultimately revised upward reflects the ongoing tension between the goal of controlling liability costs and the goal of compensating seriously injured patients fairly. Other states, including Colorado, have followed with their own scheduled increases.

Source: AB 35, Civil damages: medical malpractice (amending Civil Code 3333.2), California Legislature

3The Effect on Premiums

Of all the claims made for tort reform, one is best supported by the evidence: that caps reduce liability insurance premiums. This is where proponents stand on the firmest empirical ground.

A review of the empirical literature concluded that the better-designed studies show damages caps reduce liability insurance premiums, and the Congressional Budget Office's 2004 analysis found that caps on non-economic damages were associated with reductions in malpractice premiums, though the magnitude and duration varied. The payment data is consistent with a premium effect: an analysis of National Practitioner Data Bank payments found that cap states averaged about $217,000 per malpractice payment versus about $292,000 in no-cap states, a gap of roughly 34 percent, with California's MICRA producing one of the largest effects despite California being among the most-litigated states.

The evidence is not unanimous, however. The Government Accountability Office, examining malpractice premium trends, found that the relationship between caps and premium reduction was not uniformly demonstrated across all states, and that premium levels are influenced by many factors beyond caps, including insurer investment returns and the underwriting cycle. The honest summary is that caps tend to lower premiums and payments, the direction of the effect is well supported, but the size is variable and other forces also drive premiums. This is the reform claim on which proponents and the data most nearly agree, even if the magnitude remains debated. The broader landscape of what physicians actually pay is covered in our review of medical malpractice insurance statistics.

Source: Damages Caps in Medical Malpractice Cases, empirical review (PMC) | National Practitioner Data Bank Public Use Data File, HRSA

4Defensive Medicine and Costs

Where the premium evidence is relatively clear, the evidence on defensive medicine and overall health costs is genuinely mixed, and this is where much of the policy debate actually lives.

Some studies, notably work by Kessler and McClellan, find that liability-reducing reforms reduce defensive medicine, the ordering of tests and procedures primarily to reduce litigation exposure. A systematic review found that non-economic caps were associated with decreased health care utilization and spending and an increase in physician supply. But other studies find little effect on how physicians actually practice, and one influential analysis found that caps had no measurable impact on consumer health-insurance premiums. A frequently cited reason is scale: the economist Patricia Danzon has noted that malpractice premiums constitute less than 2 percent of total health care costs, so even large percentage changes in premiums have small effects on overall spending.

There are also findings that cut against the reform narrative. Currie and MacLeod found that caps on non-economic damages were associated with an increase in the frequency of Cesarean sections, a result suggesting caps can change physician behavior in unintended and not necessarily beneficial ways. The overall picture on defensive medicine and consumer costs is one of genuine scientific uncertainty: the effects are real in some studies, negligible in others, and occasionally counterproductive. Anyone who presents the defensive-medicine savings from caps as settled is overstating the evidence in either direction.

Source: Tort reform, defensive medicine, and physician supply, systematic review (PMC) | Danzon on malpractice premiums as share of costs (PMC)

5The Constitutional Divide

Beyond the empirical debate lies a legal one: whether damage caps are even permissible under state constitutions. Courts have split sharply, and the map of enforceable caps has shifted repeatedly as a result.

At least eight to nine states have had their medical malpractice damage caps declared unconstitutional by their supreme courts, including Georgia in Atlanta Oculoplastic Surgery v. Nestlehutt (2010), Illinois in Lebron v. Gottlieb Memorial Hospital (2010), Florida in North Broward Hospital District v. Kalitan (2017), and Kansas in Hilburn v. Enerpipe (2019). The most common constitutional grounds are that caps infringe the right to a jury trial by nullifying the jury's determination of damages, or that they violate equal protection by treating the most severely injured plaintiffs the same as those with minor injuries. A further group of states, including Arizona, Arkansas, Kentucky, Pennsylvania, and Wyoming, have constitutions that expressly prohibit such caps.

The constitutional picture is genuinely unsettled and continues to move. Some states have re-passed caps after their courts struck the original version down, occasionally drafting the new statute specifically to survive the earlier objection, as Ohio did. Others have reversed themselves over time. West Virginia's cap was struck down in one line of cases and addressed by later legislation. This ongoing legal churn means that any state-by-state cap table is a snapshot, accurate as of its date but subject to change with the next court decision or legislative session. For providers, the practical takeaway is that the liability environment is not fixed even within a single state. Where caps are absent or struck down, verdicts can reach the levels documented in our review of wrongful death verdict and settlement statistics, and the underlying cost of defending any claim is examined in our analysis of the cost of a dental malpractice lawsuit.

Source: Caps on compensatory damages and constitutional status, state law summary

6The Tradeoffs

Underlying the statistics is a genuine policy tradeoff that the data can inform but not resolve. Reform proponents and critics are, in large part, weighing different values, not just different evidence.

Proponents, primarily physician and hospital groups, argue that caps reduce premiums, stabilize the supply of physicians in high-risk specialties such as obstetrics and neurosurgery, and reduce defensive medicine, and the data supports the premium claim most strongly and the physician-supply claim moderately, with some studies finding modest gains concentrated in rural and high-risk areas. Critics, including patient-advocacy and consumer groups and trial lawyers, argue that caps fall hardest on the most catastrophically injured patients, particularly those with limited economic losses such as children, retirees, and homemakers, whose recovery is overwhelmingly non-economic, and that capping their recovery can make even clear-liability cases economically unfeasible to litigate. Both of these points are supported by evidence; they simply weigh different interests.

This is where the discussion connects to what a sedation provider can control. Tort reform is a policy variable set by legislatures and courts, outside any individual practice's influence. What a provider can influence is the strength of their documentation, which affects whether a claim arises and how it resolves regardless of the cap regime. This is where iSedate's SedationVault fits. By pulling vitals directly from compatible monitors such as Edan, MindRay, and Criticare, timestamping each entry, and producing an audit-ready PDF, SedationVault helps a practice build the contemporaneous record that governs claim outcomes in every state, whether or not that state caps damages. It does not change the law, reduce premiums by itself, or substitute for sound clinical care. What it does is strengthen the one factor within a provider's direct control.

Source: Physician supply and reform effects, systematic review (PMC) | Policy tradeoffs of damage caps, legal reference

Every Statistic in One Table

Frequently Asked Questions